Search Results 171-180 of 16078 for pharmacogenetics

  1. Implementing Genomic Medicine in a Federally Qualified Health Center to Characterize Healthcare Provider and Patients Experiences - Mayo Clinic

    About this study. The purpose of this study is to characterize healthcare provider experiences caring for Latino/a patients receiving PRS in a Federally ...

  2. A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral Sclerosis - Mayo Clinic

    This first-in-human, double-blind, placebo-controlled Phase I study will be conducted in participants with amyotrophic lateral sclerosis (ALS) to explore safety ...

  3. S1304, Carfilzomib and Dexamethasone for Treating Patients With Relapsed or Refractory Myeloma - Mayo Clinic

    Carfilzomib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Drugs used in chemotherapy, such as dexamethasone, work ...

  4. A Pilot Study Utilizing Proteomic and Genomic Profiling for Patients With Metastatic Breast Cancer - Mayo Clinic

    This study will use proteomic and genomic profiling to analyze tumor tissue to see if treatment selected by this analysis will benefit patients. Participation ...

  5. Cardiovascular Medicine - Clinical trials - Mayo Clinic

    Genetic testing can be performed in utero, but there is risk to the pregnancy and the fetus. Although some fetuses present with arrhythmias easily recognized as ...

  6. Focus Areas - Department of Molecular Pharmacology and Experimental Therapeutics Research - Mayo Clinic Research

    The Department of Molecular Pharmacology and Experimental Therapeutics at Mayo Clinic has multiple laboratories exploring a range of research focus areas.

  7. A Study of Phenotypic and Genetic Analysis of Vascular Overgrowth Syndromes - Mayo Clinic

    About this study. The purpose of this research is to develop a better understanding of the cause of vascular overgrowth syndromes and to develop a ...

  8. International research team identifies genetic-based model for predicting outcomes in primary Myelofibrosis - Mayo Clinic News Network

    ATLANTA – A group of investigators from Mayo Clinic and multiple academic research centers in Italy have identified a genetic model for predicting outcomes ...

  9. A Study Next Generation Sequencing (NGS) that May Help Identify Useful Genetic Information in Patients with Genetic Kidney Disease - Mayo Clinic

    The purpose of this study approach aims to identify exomic alterations that contribute to the development of kidney disease. Participation eligibility.

  10. Cardiac Channelopathies - Sudden Death Genomics: Michael J. Ackerman - Mayo Clinic Research

    The Ackerman Sudden Death Genomics Lab at Mayo Clinic is studying cardiac channelopathies related to long QT syndrome and catecholaminergic polymorphic ...